NBN p.Arg89Ter
c.265C>T · rs1057516320 · VCV370213
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function; NMD-escape possible for C-terminal truncations |
|---|---|---|
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.7 | GERP -0.84, phastCons 0.004 |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.0022% | 45,538 |
| European (non-Finnish) | 0.000169% | 589,974 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NBN
- Protein
- p.Arg89Ter
- Coding
- c.265C>T
- MANE Select
- NM_057091 · reported on NM_002485
- dbSNP
- rs1057516320
- Type
- single nucleotide variant
- Location
- chr8:89981430 (GRCh38)
- Structure
- AlphaFold pLDDT 75.83 · 5 PDB
- Residue 89
- the 'disordered' region
Disease context
Also linked: gastric canceracute lymphoblastic leukemiaNijmegen breakage syndromehereditary neoplastic syndromeaplastic anemia
Similar variants
- NBN p.Arg89= Likely benign ★★ same residue
- NBN p.Arg89Gln Conflicting classifications of pathogenicity ★ ⚠ same residue
- NBN p.Arg89Gly Uncertain significance ★ ⚠ same residue
- NBN p.Arg89Pro Conflicting classifications of pathogenicity ★ ⚠ same residue
- NBN p.Arg89Leu Uncertain significance ⚠ same residue
- ARTN p.Ala89Thr Uncertain significance ★ ⚠ same residue
- NBN c.1124+1G>C Likely pathogenic ★★ same condition
- NBN c.1124+2T>G Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nbn-p-arg89ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown